Drug resistance mechanisms in cancers: Execution of pro-survival strategies
The Journal of Biomedical Research · 2024 · 38 (2) · 95
DOI: 10.7555/jbr.37.20230248 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Biomedical Research, 2024. Verfasst von Pavan Kumar Dhanyamraju. Beteiligte Einrichtung: Fels Cancer Institute of Personalized Medicine, Lewis-Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fels Cancer Institute of Personalized Medicine, Lewis-Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Zitieren
APA
Dhanyamraju, P. K. (2024). Drug resistance mechanisms in cancers: Execution of pro-survival strategies. The Journal of Biomedical Research, 38(2), 95. https://doi.org/10.7555/jbr.37.20230248
Vancouver
Dhanyamraju PK. Drug resistance mechanisms in cancers: Execution of pro-survival strategies. The Journal of Biomedical Research. 2024;38(2):95. doi:10.7555/jbr.37.20230248
BibTeX
@article{Dhanyamraju2024,
author = {Dhanyamraju, Pavan Kumar},
title = {Drug resistance mechanisms in cancers: Execution of pro-survival strategies},
journal = {The Journal of Biomedical Research},
year = {2024},
volume = {38},
number = {2},
pages = {95},
doi = {10.7555/jbr.37.20230248}
}
EUVIMED